Pande Atul's Insider Trades & SAST Disclosures
Pande Atul's most recent trade in Immunovant Inc was a trade of 7,750 Common Stock done at an average price of $28.5 . Disclosure was reported to the exchange on Dec. 2, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Pande Atul.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Pande Atul | Director | Sale of securities on an exchange or to another person at price $ 28.54 per share. | 02 Dec 2024 | 7,750 | 86,663 (0%) | 0% | 28.5 | 221,185 | Common Stock |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 11,255 | 94,413 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 4,690 | 4,690 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 40.46 per share. | 01 Dec 2023 | 4,847 | 83,158 (0%) | 0% | 40.5 | 196,110 | Common Stock |
| Immunovant Inc | Pande Atul | Director | Sale of securities on an exchange or to another person at price $ 38.80 per share. | 01 Dec 2023 | 4,129 | 91,379 (0%) | 0% | 38.8 | 160,205 | Common Stock |
| Immunovant Inc | Pande Atul | Director | Sale of securities on an exchange or to another person at price $ 39.82 per share. | 01 Dec 2023 | 3,374 | 88,005 (0%) | 0% | 39.8 | 134,353 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 1,904 | 1,904 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2023 | 990 | 990 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 16,260 | 16,260 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 12,523 | 95,508 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Atul Pande | Director | Purchase of securities on an exchange or from another person at price $ 5.60 per share. | 30 Sep 2022 | 15,000 | 20,000 (0%) | 0% | 5.6 | 84,000 | Common Stock |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 31,668 | 31,668 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 21,059 | 82,985 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 5,000 | 5,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2022 | 2,500 | 0 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Feb 2022 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 110.80 per share. | 01 Feb 2022 | 2,500 | 0 (0%) | 0% | 110.8 | 277,000 | Common Stock |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 71,492 | 208,973 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2022 | 21,726 | 61,926 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,500 | 2,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 03 Jan 2022 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 130.44 per share. | 03 Jan 2022 | 2,500 | 0 (0%) | 0% | 130.4 | 326,100 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 127.73 per share. | 01 Dec 2021 | 2,500 | 0 (0%) | 0% | 127.7 | 319,325 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 2,500 | 5,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Dec 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 136.67 per share. | 01 Nov 2021 | 2,500 | 0 (0%) | 0% | 136.7 | 341,675 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 2,500 | 7,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Nov 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 2,500 | 10,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 120.72 per share. | 01 Oct 2021 | 2,500 | 0 (0%) | 0% | 120.7 | 301,800 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Oct 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 117.82 per share. | 01 Sep 2021 | 2,500 | 0 (0%) | 0% | 117.8 | 294,550 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 2,500 | 12,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Sep 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Immunovant Inc | Atul Pande | Director | Purchase of securities on an exchange or from another person at price $ 7.98 per share. | 13 Aug 2021 | 5,000 | 45,200 (0%) | 0% | 8.0 | 39,900 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 02 Aug 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Aug 2021 | 2,500 | 15,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 114.17 per share. | 02 Aug 2021 | 2,500 | 0 (0%) | 0% | 114.2 | 285,425 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 112.66 per share. | 01 Jul 2021 | 2,500 | 0 (0%) | 0% | 112.7 | 281,650 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 2,500 | 17,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Jul 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 8,500 | 8,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Jun 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 2,500 | 20,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 111.44 per share. | 01 Jun 2021 | 2,500 | 0 (0%) | 0% | 111.4 | 278,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Apr 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 110.61 per share. | 01 Apr 2021 | 2,500 | 0 (0%) | 0% | 110.6 | 276,525 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 2,500 | 25,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 2,500 | 22,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Apr 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 120.01 per share. | 01 Apr 2021 | 2,500 | 0 (0%) | 0% | 120.0 | 300,025 | Common Stock |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 23,300 | 23,300 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 15,500 | 40,200 (0%) | 0% | 0 | Common Stock | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Mar 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 2,500 | 27,500 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 125.43 per share. | 01 Mar 2021 | 2,500 | 0 (0%) | 0% | 125.4 | 313,575 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 01 Feb 2021 | 2,500 | 0 (0%) | 0% | 100 | 250,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 2,500 | 30,000 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.00 per share. | 01 Feb 2021 | 2,500 | 2,500 (0%) | 0% | 16 | 40,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2020 | 5,714 | 0 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 14 Dec 2020 | 5,714 | 5,714 (0%) | 0% | 2.9 | 16,685 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 92.64 per share. | 14 Dec 2020 | 5,714 | 0 (0%) | 0% | 92.6 | 529,345 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 12 Nov 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 96.84 per share. | 12 Nov 2020 | 5,000 | 0 (0%) | 0% | 96.8 | 484,200 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2020 | 5,000 | 5,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2020 | 5,000 | 10,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 03 Nov 2020 | 5,000 | 0 (0%) | 0% | 85 | 425,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 03 Nov 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 16 Sep 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2020 | 5,000 | 15,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 16 Sep 2020 | 5,000 | 0 (0%) | 0% | 85 | 425,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 12 Aug 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 5,000 | 20,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 12 Aug 2020 | 5,000 | 0 (0%) | 0% | 85 | 425,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 12 Aug 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2020 | 5,000 | 20,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 12 Aug 2020 | 5,000 | 0 (0%) | 0% | 85 | 425,000 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 95.43 per share. | 13 Jul 2020 | 5,000 | 0 (0%) | 0% | 95.4 | 477,150 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 13 Jul 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2020 | 5,000 | 25,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2020 | 5,000 | 30,714 | - | - | Option (right to buy) | |
| Karuna Therapeutics Inc | Atul Pande | Director | Sale of securities on an exchange or to another person at price $ 93.27 per share. | 12 Jun 2020 | 5,000 | 0 (0%) | 0% | 93.3 | 466,350 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.92 per share. | 12 Jun 2020 | 5,000 | 5,000 (0%) | 0% | 2.9 | 14,600 | Common Stock |
| Karuna Therapeutics Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 12,500 | 12,500 | - | - | Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 37,000 | 37,000 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Atul Pande | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 24,700 | 24,700 (0%) | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges